A pioneering UK trial will allow patients with advanced bladder to receive personalised drug treatments depending on the DNA in their tumours.Currently the deadly disease is treated using chemotherapy, surgery and sometimes radiotherapy. However, research suggests some patients would do better on new drugs known as immunotherapy that are tailored to boost an individual’s immune system.Other patients do not respond to either chemotherapy or immunotherapy and their only hope is immediate surgery to try to root out the tumours.
Load More
Load More